Concomitant inhibition of renin angiotensin system and Toll-like receptor 2 attenuates renal injury in unilateral ureteral obstructed mice.
- Author:
Sarah CHUNG
1
;
Jin Young JEONG
;
Yoon Kyung CHANG
;
Dae Eun CHOI
;
Ki Ryang NA
;
Beom Jin LIM
;
Kang Wook LEE
Author Information
- Publication Type:Original Article
- Keywords: Toll-like receptor 2; Renin-angiotensin system; Unilateral ureteral obstruction
- MeSH: Amides/*pharmacology; Angiotensin II/pharmacology; Animals; Disease Models, Animal; Fibrosis; Fumarates/*pharmacology; Kidney/*drug effects/metabolism/pathology; Male; Mice, Inbred C57BL; Mice, Knockout; Nephritis, Interstitial/genetics/metabolism/pathology/*prevention & control; RNA, Messenger/genetics/metabolism; Renin/*antagonists & inhibitors/metabolism; Renin-Angiotensin System/*drug effects; Toll-Like Receptor 2/deficiency/drug effects/genetics/*metabolism; Ureteral Obstruction/*drug therapy/genetics/metabolism/pathology
- From:The Korean Journal of Internal Medicine 2016;31(2):323-334
- CountryRepublic of Korea
- Language:English
- Abstract: BACKGROUND/AIMS: There has been controversy about the role of Toll-like receptor 2 (TLR2) in renal injury following ureteric obstruction. Although inhibition of the renin angiotensin system (RAS) reduces TLR2 expression in mice, the exact relationship between TLR2 and RAS is not known. The aim of this study was to determine whether the RAS modulates TLR2. METHODS: We used 8-week-old male wild type (WT) and TLR2-knockout (KO) mice on a C57Bl/6 background. Unilateral ureteral obstruction (UUO) was induced by complete ligation of the left ureter. Angiotensin (Ang) II (1,000 ng/kg/min) and the direct renin inhibitor aliskiren (25 mg/kg/day) were administrated to mice using an osmotic minipump. Molecular and histologic evaluations were performed. RESULTS: Ang II infusion increased mRNA expression of TLR2 in WT mouse kidneys (p < 0.05). The expression of renin mRNA in TLR2-KO UUO kidneys was significantly higher than that in WT UUO kidneys (p < 0.05). There were no differences in tissue injury score or mRNA expression of monocyte chemotactic protein 1 (MCP-1), osteopontin (OPN), or transforming growth factor beta (TGF-beta) between TLR2-KO UUO and WT UUO kidneys. However, aliskiren decreased the tissue injury score and mRNA expression of TLR2, MCP-1, OPN, and TGF-beta in WT UUO kidneys (p < 0.05). Aliskiren-treated TLR2-KO UUO kidneys showed less kidney injury than aliskiren-treated WT UUO kidneys. CONCLUSIONS: TLR2 deletion induced activation of the RAS in UUO kidneys. Moreover, inhibition of both RAS and TLR2 had an additive ameliorative effect on UUO injury of the kidney.
